EP Patent

EP3359146A1 — Pharmaceutical compositions and uses directed to lysosomal storage disorders

Assigned to Intrabio Ltd · Expires 2018-08-15 · 8y expired

What this patent protects

The present disclosure provides for treating lysosomal storage disorders (LSDs) comprising administering acetyl-leucine or a pharmaceutically acceptable salt thereof.

USPTO Abstract

The present disclosure provides for treating lysosomal storage disorders (LSDs) comprising administering acetyl-leucine or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3359146A1
Jurisdiction
EP
Classification
—
Expires
2018-08-15
Drug substance claim
No
Drug product claim
No
Assignee
Intrabio Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.